Status:
UNKNOWN
Linking Women to PrEP Care
Lead Sponsor:
Rhode Island Hospital
Conditions:
Prevention
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Pre-exposure prophylaxis (PrEP) can be very effective at preventing HIV infection among women at high-risk for HIV but is underused in this population. Periods of incarceration represent an opportunit...
Detailed Description
Incarcerated women engage in high rates of sex- and drug-related behavior that place them at risk for HIV. Pre-exposure prophylaxis (PrEP) is an efficacious means of reducing HIV acquisition. There is...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Female at birth; at least 18 years of age; not currently pregnant; risk behavior prior to incarceration that meets CDC indications for PrEP; likely to be incarcerated for less than 6 months; able to understand and speak English and to provide written and verbal informed consent
Exclusion
Key Trial Info
Start Date :
November 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03281343
Start Date
November 29 2017
End Date
August 31 2023
Last Update
April 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02903